Insider trade

Wave Life Sciences (WVE)CEO sold ~$750K

Paul Bolno, CEO at Wave Life Sciences, sold ~$750K of Wave Life Sciences shares.

~$750K
Approx. value · 50K sh @ $15.00: 217K
Holds after · shares reported

Traded: Nov 25, 2024
Filed: Nov 28, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Sep 27, 2024Insider10% owner purchased ~$22.3M of WVE shares in the open market
Oct 16, 2024Insider · 2 peopleInsiders: 5 sales (~$4.2M)
Nov 8, 2024InsiderOfficer sold ~$576K of WVE shares in the open market
Nov 15, 2024InsiderCEO sold ~$734K of WVE shares in the open market
Nov 25, 2024 · this disclosureInsiderCEO sold ~$750K of WVE shares in the open market

What came next

Mar 7, 2025InsiderCEO sold ~$1.62M of WVE shares in the open market
Mar 20, 2025InsiderDirector sold ~$103K of WVE shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Wave Life Sciences

OQRO holds no insider, Congress, fund or contract record for Wave Life Sciences dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its WVE page.

Other recent filings by Paul Bolno, President and CEO

The full history of Paul Bolno, President and CEO is on the profile page.

How this filing works

Other disclosures at Wave Life Sciences

Everything OQRO holds on this company is on its WVE page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data